Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    15771580 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Evaluation of PD1 / PDL1 Expression on Blood Cells & Tumor Tissue, Their Role as a Prognostic Target in NSCLC Patients
Condition: Non-Small Cell Lung Cancer
Intervention: Other: Evaluation of PD-1/PDL-1 expression.
2 Unknown  Latency in Pulmonary Tuberculosis
Condition: Pulmonary Tuberculosis
Intervention: Drug: Moxifloxacin, Isoniazid, Rifampicin Pyrazinamide, Ethambutol

Indicates status has not been verified in more than two years